BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 9490238)

  • 1. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
    Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Stebbins AL; Granger CB; Suarez LD; Borruel M; Gates K; Starr S; Wagner GS
    J Am Coll Cardiol; 1997 Mar; 29(4):770-7. PubMed ID: 9091523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
    Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
    J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Knight D; Mark DB; Granger CB; Agranatti DA; Mautner B; Ohman EM; Suárez LD; Armstrong PW; Gates K; Wagner GS
    Am J Cardiol; 2000 Jul; 86(1):24-9. PubMed ID: 10867087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
    Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Langer A; Krucoff MW; Klootwijk P; Veldkamp R; Simoons ML; Granger C; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1995 Jun; 25(7):1552-7. PubMed ID: 7759706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Q- and Q-wave infarction after thrombolytic therapy with intravenous streptokinase for chest pain and anterior ST-segment elevation.
    Chouhan L; Hajar HA; George T; Pomposiello JC
    Am J Cardiol; 1991 Aug; 68(5):446-50. PubMed ID: 1872269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Lundergan CF; Reiner JS; McCarthy WF; Coyne KS; Califf RM; Ross AM
    J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
    Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
    J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
    White HD; Cross DB; Elliott JM; Norris RM; Yee TW
    Circulation; 1994 Jan; 89(1):61-7. PubMed ID: 8281696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Tardiff BE; Califf RM; Morris D; Bates E; Woodlief LH; Lee KL; Green C; Rutsch W; Betriu A; Aylward PE; Topol EJ
    J Am Coll Cardiol; 1997 Feb; 29(2):240-9. PubMed ID: 9014973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study.
    Aguirre FV; Younis LT; Chaitman BR; Ross AM; McMahon RP; Kern MJ; Berger PB; Sopko G; Rogers WJ; Shaw L
    Circulation; 1995 May; 91(10):2541-8. PubMed ID: 7743615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: clinical and angiographic study.
    Matetzky S; Barabash GI; Shahar A; Rabinowitz B; Rath S; Zahav YH; Agranat O; Kaplinsky E; Hod H
    J Am Coll Cardiol; 1994 Aug; 24(2):378-83. PubMed ID: 8034871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.